This PR indicates that we’re overdue for an upda
Post# of 148173
(Total Views: 530)
Posted On: 04/03/2020 8:21:00 AM
This PR indicates that we’re overdue for an update on the cancer trials. I’m hoping, with a lull in COVID19 news coming in the next week or more, that we see a PR on the additional breast cancer patients AND information on the basket trial patients.
Data showing efficacy in the basket trial patients will be blockbuster. I don’t know if it will move the SP much, but just like in the early HIV, mTNBc, and now COVID19 patients, leronlimab typically shows efficacy and then continues to repeat it in subsequent patients.
Data showing efficacy in the basket trial patients will be blockbuster. I don’t know if it will move the SP much, but just like in the early HIV, mTNBc, and now COVID19 patients, leronlimab typically shows efficacy and then continues to repeat it in subsequent patients.
(0)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼